| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
6e-09 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-08 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-07 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |
| mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
6e-05 |